申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US05453514A1
公开(公告)日:1995-09-26
A Maillard reaction inhibitor containing, as an active ingredient, an amidinoheterocyclic derivative or its pharmaceutically acceptable salt, which is useful for the prevention and/or cure of various complications of diabetes and maturity-onset disorders. The amidinoheterocyclic derivatives are also useful as Maillard reaction inhibitors for cosmetics, external endermic medicines, foods, drinks, luxury grocery items and functional foods.
一种含有阿米烯杂环衍生物或其药用可接受盐的美拉德反应抑制剂,作为活性成分,可用于预防和/或治疗糖尿病和成熟起始障碍的各种并发症。这些阿米烯杂环衍生物也可作为美拉德反应抑制剂用于化妆品、外用内皮药物、食品、饮料、奢侈杂货和功能性食品。